Brookstone

Acella Pharmaceuticals, formerly known as Brookstone Pharmaceuticals, is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable healthcare solutions. The company maintains a diverse portfolio of products across several therapeutic areas, including endocrinology, dermatology, and prenatal health. Its flagship product, NP Thyroid, is a naturally derived thyroid hormone replacement therapy used to treat hypothyroidism. Acella also provides a range of prenatal vitamins and dermatological treatments, positioning itself as a key player in the specialty generic and branded pharmaceutical markets.